Markers of cellular differentiation in acute lymphoblastic leukemia.

Publication/Presentation Date

1-1-1982

Abstract

Acute lymphoblastic leukemia (ALL) is a heterogeneous entity that can be subcategorized on the basis of morphologic aspects, immunologic markers, membrane antigens, and enzymatic content of the blast forms. Subgroups corresponding to T-cell, pre-T-cell, pre-B-cell, and non-T-, non-B-lymphocyte derivations can be defined by immunologic markers, and the biologic differences are supported by the differential expression of membrane antigens and of nuclear, lysosomal, cytoplasmic, and membrane enzymes. These studies ease the diagnosis and characterization of ALL and enhance understanding of this disease.

Volume

106

Issue

1

First Page

3

Last Page

8

ISSN

0003-9985

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

6976157

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS